Home › Therapeutic areas › Oncology › Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia (4 companies)
Companies with an active program in Acute Lymphoblastic Leukemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics | Oncology | 1 | — | $203M | 6 |
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 3 | Approved | $341M | 12 |
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | $647M | 12 |
| SLS | SELLAS Life Sciences Group | Oncology | 1 | Phase 3 | $1.70B | 9 |
No companies match.